Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ "<x&pQZ%
y
AOg\+
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© Oqmg;\pm
d&u7]<yDA
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© um[!
|g/
Yx
),6C3
1.Co-stimulators (or co-stimulating molecules) GRIa8>
\?&Au
2.NK-kB YjLe(+WQ
B+Z13;}B
3.Immunoglobulin superfamily hiwIWd:H
0[)VO[
4.antigen-presenting cell (APC) j#VIHCz
lr
U^rm:*f
5.death domain ax_YKJ5#P
8;#AO8+U7)
6.CCR and CXCR
rN"Xz
Obo _Y
E
7.Lectin (or mitogen) aD ESr?
/.$L"u
8.Clusters of differentiation, CD) C),7- ?
nm @']
9.B7 family
{155b0
?4G(N=/&
10.Cytotoxic T lymphocyte, CTL) w!`Umll2
`*yAiv>
11.IL-15 and IL-15 receptor (IL-15R) ooE{V*Ie
2\0Oji\6
12.MHC restriction 1b3(
mW4%2fD[
13.Affinity-chromatography f^9&WT
>uy%-aXiVa
14.Cyctosprin A, CsA JE!("]&
)~
z Z'^
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) 4o5i ."l
vM`~)rO@!
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© Zw$
OKU
G{RTH_p
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 ;6m;M63 z
ZL_[4Y
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ mqFq_UX/T
% fhNxR
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ JsQ6l%9
l,d, T
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© "!Lkp2\
[B9 ;?G
ÃâÒßѧרҵ£º GGnp Pp
Do*n#=
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ .y): Rh^
n29(!10Px
Ïû»¯ÄÚ¿Æ£º NL!9U,h5|
S_Z`so
}
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ T~ k)uQ
/1fwl5\
ѪҺ²¡Ñ§×¨Òµ£º
`w<J25
g1|w? pI1
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿